Follistatin 344
A compound aimed at unlocking muscle growth by releasing the body's natural brake on it. A myostatin antagonist that binds and neutralizes myostatin, the negative regulator of muscle growth. Theoretical muscle-growth signal, limited human data.
Follistatin 344: A compound aimed at unlocking muscle growth by releasing the body's natural brake on it. A myostatin antagonist that binds and neutralizes myostatin, the negative regulator of muscle growth. Theoretical muscle-growth signal, limited human data. Follistatin 344 blocks myostatin, the protein that puts a ceiling on how much muscle you can build.
Follistatin 344 blocks myostatin, the protein that puts a ceiling on how much muscle you can build. Theoretically removing the brake means more muscle growth. Real human data is very limited. Treat as experimental, run short cycles only.
Not prescribed in conventional medicine.
Who it's for
- →Bodybuilders / lifters experimenting with muscle-growth pathways
- →Researchers studying myostatin biology
What to expect
- Week 1
Anecdotal pumps and fullness reports.
- Week 4
Subjective effects peak around here for responders. Cycle endpoint, stop.
- Week 8
Off-cycle. No long-cycle data exists.
Looking at Follistatin 344? Your next 3 steps
- 1Work out your syringe units
Vial size + BAC water turns into the exact units to draw for Follistatin 344.
Open calculator → - 2See what to stack & monitor
The companion supplements and the bloodwork worth tracking on this kind of protocol.
Bloodwork guide → - 3Save it & ask the Coach
A free account gets you Coach questions every day, free; membership saves your stack and makes the Coach stack-aware.
Create free account →
How it works (mechanism)
Glycoprotein that binds and neutralizes myostatin. Different mechanism from ACE-031, direct ligand-binding rather than receptor-decoy. Theoretically permits increased muscle growth by removing the negative regulator.
Dosing protocol
Stacks well with
Side effects
When NOT to use
- ⚠Anyone risk-averse to limited human data
- ⚠Pregnancy / nursing
- ⚠Active malignancy
Common mistakes
- • Running it longer than 30 days without safety data
- • Treating it as steroid-equivalent (it isn't)
- • Stacking with too many other compounds and crediting Follistatin for everything
What it actually is
Follistatin 344 is a version of a naturally occurring protein that binds and neutralises myostatin, the signal that limits how much muscle your body will build. The idea is to release the brake rather than press the accelerator. It has essentially no human evidence: five indexed papers, of which two are about detecting it on the black market and one is a case series of eye damage in people who used it.
Myostatin is a member of the TGF-beta family that continuously signals muscle to stop growing. Animals and the rare humans with a broken myostatin gene are dramatically more muscular. Follistatin binds myostatin and prevents that signal reaching its receptor, so in principle muscle grows past its normal ceiling. The catch is that follistatin does not bind myostatin alone — it neutralises several related TGF-beta family ligands that do jobs elsewhere in the body, which is where the unexpected harms come from.
Forms, and which is which
Buyer reconstitutes. A large protein sold as a research chemical, where identity is impossible to verify and correct folding matters.
Verdict: The only form, and the hardest kind of molecule to verify.
Studied in muscular dystrophy trials as a gene therapy, a completely different proposition from injecting a protein.
Verdict: Real research, unrelated to what is sold.
A decoy receptor that traps myostatin. Its clinical programme was halted over vascular safety signals.
Verdict: Same target, and its trials were stopped for cause.
Supplements claiming to raise follistatin, usually egg-derived. No mechanism supports a meaningful effect.
Verdict: Unrelated to the injectable claim.
What it is claimed to do, graded
Zero human trials. The evidence index returns five papers total for this compound and none of them is an efficacy study.
The biochemistry is real and well established for follistatin as a protein. Whether an injected research-chemical preparation does it in a person is untested.
A 2020 retrospective case series reported central serous chorioretinopathy — fluid under the retina, causing vision distortion — in people using high-dose follistatin-344. That is a documented harm in exactly this population, not a theoretical one.
Widely claimed and untested.
Grades describe how much human evidence exists for that specific claim, not whether it will work for you or whether it is safe.
Pros and cons
- • The myostatin biology is genuine and one of the better-understood limits on muscle growth
- • Short protocols limit total exposure
- • The mechanism is different from anything hormonal, so it does not carry the endocrine side effects
- • Zero human trials — grade F on the site's own ladder
- • A documented eye harm in real users: central serous chorioretinopathy at high doses
- • Follistatin neutralises several TGF-beta ligands, not myostatin alone, so off-target effects are expected rather than surprising
- • The other drug aimed at this target had its trials halted over vascular safety
- • A large protein sold as a research chemical is the hardest category to verify
- • Banned in sport
When to stop
- • Any change in vision — blurring, a dark or distorted patch in central vision. This is the documented harm, take it seriously and get seen
- • Thirty days, on any protocol — there is no safety data supporting longer
- • Tendon or joint pain as strength climbs
- • Any new cancer diagnosis
Interactions
Same pathway, compounded off-target suppression, and the other agent's trials were halted for safety.
TGF-beta signalling is central to tumour biology in both directions. Broad suppression in a body with a tumour is unstudied.
Commonly stacked. It makes any effect unattributable and compounds tendon loading against a rapidly growing muscle.
Muscle can gain force capacity faster than tendon adapts, which is a plausible injury mechanism and a recognised theoretical concern with strong myostatin suppression.
There is no human interaction literature for this compound.
Is this for you?
- • Realistically nobody on the current evidence, given a documented eye harm and no efficacy data
- • You value your vision — the reported harm is retinal and occurred in users at high doses
- • You have active cancer
- • You are pregnant or nursing
- • You are drug-tested in sport
The one number
Sources for the claims above
- Central serous chorioretinopathy associated with high-dose follistatin-344
- Detection of black market follistatin 344
- Listed among unapproved peptide therapies for musculoskeletal use
New to Follistatin 344? Grab the starter checklist.
Drop your email and we'll send the one-page starter checklist beginners actually need first. No account needed.
No spam, and we never sell your email. Just the checklist. Email support@pepdex.co to opt out any time.
Numbers redacted in this preview. Members get the full answer, on their own stack.
Ask the Coach anything about Follistatin 344 or your own stack. This is it working.
Trained only on Pepdex content. Does the dose math, flags interactions, knows your stack. Won't push vendors, won't pretend to be a doctor.
Unlock the full Coach, from $4.99/week →Frequently asked
What is Follistatin 344?+
Is Follistatin 344 FDA approved?+
Is Follistatin 344 legal?+
Is Follistatin 344 banned by WADA?+
Are you still natty after taking Follistatin 344?+
Do doctors prescribe Follistatin 344?+
What's the typical dose of Follistatin 344?+
What are the side effects of Follistatin 344?+
How long until Follistatin 344 starts working?+
What can you stack with Follistatin 344?+
Where do people get Follistatin 344?+
Common questions about Follistatin 344
Tracked alongside Follistatin 344
Same goal, different aisle — each graded on its own evidence in the Pepdex catalog.
More in GH-axis
Recombinant human growth hormone, the protein itself, not a peptide that nudges your body to make more. Highest legal-risk compound in this catalog.
Oral ghrelin mimetic. Bumps GH and IGF-1 without injections. Strong appetite stimulation is the trade-off.
Bumps your natural growth-hormone pulses without hitting cortisol or prolactin. A selective GH secretagogue.
Pairs with Ipamorelin to amplify your natural growth-hormone pulses. A GHRH analog whose 'no-DAC' version stays short-acting on purpose.